Neuroscience Trials

@NeuroTrialsAus

Neuroscience Trials Australia is a niche specialising in . Our Mission-Improving life through

Vrijeme pridruživanja: svibanj 2017.

Tweetovi

Blokirali ste korisnika/cu @NeuroTrialsAus

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NeuroTrialsAus

  1. Prikvačeni tweet
    29. sij

    Did you know? Of the 13 new drugs approved by the FDA in 2016, 7 had Phase III trials conducted in Australia. Read about the takeaway messages from our Fireside Chat about the Australian clinical trial advantage

    Poništi
  2. 4. velj

    Australia is globally recognised for clinical research capabilities & healthcare infrastructure. Watch this video from & find out why Australia is your next clinical trial destination.

    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Victoria has a world class medical technologies and pharmaceutical industry and it's largely due to innovative researchers like Thomas Ko from

    Poništi
  4. proslijedio/la je Tweet

    This special issue ⬇️ will be freely available only until Feb 14! Get access before then to read the illuminating articles at: //

    Poništi
  5. proslijedio/la je Tweet
    4. velj

    📍Interested in clinical research but unsure of the path to get there? of recommends 3 steps to make clinical research your career in our latest blog post. Read here:

    Poništi
  6. proslijedio/la je Tweet
    3. velj

    Speaker Announcement! Read more about the esteemed line-up of industry experts for our 8th Annual Devices and Diagnostics Lab.

    , , i još njih 3
    Poništi
  7. proslijedio/la je Tweet

    Earlybird discounts for the Bayesian Adaptive Randomised Workshop have been extended to Fri 7 Feb. Join international experts on adaptive trials, Lorenzo Trippa & Steffen Ventz from In Melbourne 27-28 Feb and Sydney 5-6 Mar:

    Poništi
  8. proslijedio/la je Tweet
    31. sij

    and industry mentor Dr Tina Soulis () shares her advice on how to have a successful and rewarding career in clinical research. Dr Soulis is CEO and is based in Melbourne

    Poništi
  9. proslijedio/la je Tweet
    31. sij

    Our industry-led, VC-backed Accelerator Program brings radical new tech to Australian and international markets. If you have a prototype in bionics, devices, diagnostics, implants, instrumentation, AI, digital health or services, apply now at !

    , , i još njih 7
    Poništi
  10. proslijedio/la je Tweet
    31. sij

    We are excited to kick off our 2020 free public lecture series on the 12th of February with our special international guest lecturer, Dr Tracy Bale from . Join us to learn about the role of and in disease across generations!

    Poništi
  11. 30. sij

    What is the best advice to students thinking about clinical research? Our CEO spoke to about the opportunities and entry points, and shares her top hints for working in the sector

    Poništi
  12. proslijedio/la je Tweet
    Suggestions for improving stroke motor rehabilitation trials
    Poništi
  13. proslijedio/la je Tweet
    29. sij

    If you are active in the or industry & have an idea, a device in development or a product ready for market, then our 1 day symposium “Devices + Diagnostics Lab: Manufacturing, Markets & Minefields" is for you

    Poništi
  14. proslijedio/la je Tweet
    28. sij

    Decentralized clinical trials may be the key to improving participant diversity and overcoming recruitment challenges. CROs can ease challenges that come with these trials.

    Poništi
  15. proslijedio/la je Tweet
    27. sij

    Interested in ? The Program trains researchers on how to take new to market. Applications close 31 Jan, so be quick! Apply now:

    Poništi
  16. proslijedio/la je Tweet
    25. sij

    Huge congratulations to Professor Justin Yerbury AM on his award for significant services to education and research in the field of biological sciences. Very well deserved recognition 👏🏼👏🏼👏🏼👏🏼

    Poništi
  17. proslijedio/la je Tweet
    24. sij

    It takes a village to raise a – and the industry leaders in our 15-month, VC-backed Accelerator Program will help your startup achieve in 15 months what can typically take 3 years. Apply now at !

    , , i još njih 6
    Poništi
  18. proslijedio/la je Tweet
    23. sij

    Three neuroprotective drugs fail to show efficacy in secondary progressive multiple sclerosis

    Poništi
  19. proslijedio/la je Tweet
    22. sij

    From improving RNA analysis to decoding the microbiome, these are the technologies to watch in 2020.

    Poništi
  20. proslijedio/la je Tweet
    22. sij

    Save the date! Feb 25, 2020; Melbourne. We're bringing together survivors, researchers & clinicians to workshop strategies for improving inclusion and diversity across the process of stroke research. More to come 🧠🧡

    Social media tile - in the background is a darkened picture of a room of people sitting around tables, with two people standing at the front of the room. Text reads 'Inclusion and diversity in the stroke research process. Workshop. 25 Feb 2020, Melbourne. Our logo is also pictured.
    , , i još njih 5
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·